<div>This fundraiser is for my cousin, Danyella—a bright, kind, and determined 17-year-old who has spent her entire life living with sickle cell disease which is a genetic blood disorder which causes severe pain.
</div>
<div><br />
</div>
<div>Despite a lifetime of hardship, Danyella will be graduating high-school, spring of 2026, with dreams of becoming a neurologist—a goal inspired by her firsthand experience living with a disease. She has the desire to heal others. But today, she’s the one who needs healing.
</div>
<div><br />
</div>
<div><strong>What Danyella Is Going Through</strong>
</div>
<div><br />
</div>
<div>Danyella lives with constant, severe pain. She relies on morphine and other strong medications just to function. Her flare-ups are so intense that she often can't walk, and she’s frequently hospitalized. As a result, she’s unable to attend regular school, and even her online classes are hard to keep up with.
</div>
<div><br />
</div>
<div>She’s currently admitted to Children’s Hospital in Minneapolis, where her condition continues to be closely monitored.
</div>
<div><br />
</div>
<div>This is not just discomfort—this is a relentless and disabling disease that has robbed her of a normal childhood.
</div>
<div><br />
</div>
<div><strong>A Message of Medical Hope</strong>
</div>
<div><br />
</div>
<div>Danyella’s care team has confirmed that her disease status makes her a strong candidate for two potentially curative treatments:
</div>
<div><br />
</div>
<div>1. FDA-Approved Gene Therapy
</div>
<div>A breakthrough option that targets the root cause of sickle cell disease at the genetic level. It offers real hope for freedom from pain.
</div>
<div><br />
</div>
<div><br />
</div>
<div>2. Matched Unrelated Donor (MUD) Transplant
</div>
<div>Danyella has several excellent donor matches, and this transplant has been confirmed by her doctors as another viable curative approach.
</div>
<div><br />
</div>
<div>According to her providers, both gene therapy and MUD transplant are medically indicated in her case—meaning they are not just possible but recommended.
</div>
<div><br />
</div>
<div>These treatments represent Danyella’s best chance to live a pain-free, independent, and fulfilling life.
</div>
<div><br />
</div>
<div><strong>Why We’re Asking for Help</strong>
</div>
<div><br />
</div>
<div>Both options come with enormous out-of-pocket costs that insurance will not fully cover. We are urgently raising $250,000 to help with:
</div>
<div><br />
</div>
<div>Medical costs not covered by insurance
</div>
<div><br />
</div>
<div>Temporary housing, transportation, and caregiving support during recovery
</div>
<div><br />
</div>
<div><strong>How You Can Help</strong>
</div>
<div><br />
</div>
<div>We ask you to please donate what you can, share this campaign, and keep Danyella in your prayers. Every contribution, big or small, brings her closer to the care she needs—and the life she deserves.
</div>
<div><br />
</div>
<div>Your kindness could help free her from a lifetime of pain.
</div>
<div><br />
</div>
<div>With love and gratitude,
</div>
<div>— Danyella’s family
</div>

A care Staff

NICOLE GUISE

Jannette Achale

Anonymous

Sophia Williams-Ogu

DIANNE NEWTON

Andrew Brown

Zack Zielieke

Nola Howitz

Alivia Boddie

Sherwyn Jeffrey

Debra Larson

Samuel Anim

Liz-Ann Fraser

Francine Richardson

Bill mitchell

samuel garrett

Support to help Danyella fight against Sickle Cell

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Support to help Danyella fight against Sickle Cell

Still $77,959 to go. Help us build momentum.